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Abstract
Background: Arterial diameters enlarge in response to wall thickening, plaques, and many atherosclerotic risk
factors. We hypothesized that right common carotid artery (RCCA) diameter would be independently associated
with cardiac disease and improve risk discrimination.
Methods: In a middle-aged, biracial population (baseline n = 11225), we examined associations between 1
standard deviation increments of baseline RCCA diameter with prevalent myocardial infarction (MI) and incident
cardiac events (MI or cardiac death) using logistic regression and Cox proportional hazards models, respectively.
Areas under the receiver operator characteristic curve (AUC) were used to estimate model discrimination.
Results: MI was present in 451 (4%) participants at baseline (1987–89), and incident cardiac events occurred
among 646 (6%) others through 1999. Adjusting for IMT, RCCA diameter was associated with prevalent MI
(female OR = 2.0, 95%CI = 1.61–2.49; male OR = 1.16, 95% CI = 1.04–1.30) and incident cardiac events (female
HR = 1.75, 95% CI = 1.51–2.02; male HR = 1.27, 95% CI = 1.15–1.40). Associations were attenuated but persisted
after adjustment for risk factors (not including IMT) (prevalent MI: female OR = 1.73, 95% CI = 1.40–2.14; male
OR = 1.14, 95% CI = 1.02–1.28, and incident cardiac events: female HR = 1.26, 95% CI = 1.08–1.48; male HR =
1.19, 95% CI = 1.08–1.32). After additional adjustment for IMT, diameter was associated with incident cardiac
events in women (HR = 1.18, 95% CI = 1.00–1.40) and men (HR = 1.17, 95% CI = 1.06–1.29), and with prevalent
MI only in women (OR = 1.73; 95% CI = 1.37–2.17). In women, when adjustment was limited, diameter models
had larger AUC than other models.
Conclusion: RCCA diameter is an important correlate of cardiac events, independent of IMT, but adds little to
overall risk discrimination after risk factor adjustment.
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Background
Early identification of persons at high risk of cardiac
events would improve preventive and clinical care [1].
Therefore, many novel risk factors, markers [2,3] and
innovative techniques including 3-dimensional vascular
measurements have been developed [4-7] that investigate
intervening steps in the atherosclerosis progression. B-
mode ultrasound measurement of common carotid artery
(CCA) intima media thickness (IMT) is a widely available,
relatively inexpensive, highly standardized method for
evaluating presence and severity of atherosclerosis [8].
CCA IMT has been related to multiple atherosclerosis risk
factors [9,10] and to prevalent and incident coronary
heart disease (CHD) [11-16]. CCA diameter, like IMT, is
easily assessed by B-mode ultrasound and is related to
many atherosclerosis risk factors [9,17-20]. Larger exter-
nal CCA diameter has been positively related to coronary
artery disease status [21], and with acute coronary syn-
drome [22]. Because arterial diameter enlargement occurs
early in atherosclerosis [23] and is exaggerated in the pres-
ence of vulnerable plaques [24-27], CCA diameter might
improve our understanding of atherosclerosis progression
and improve prediction of cardiovascular events [19] or
vascular injury [28]. While 3-dimensional artery measure-
ments have proven very useful in evaluating atherosclero-
sis progression[29], 2-dimensional studies have not
consistently shown improvement compared to IMT
[28,30-32]. We proposed to determine whether B-mode
ultrasound right CCA (RCCA) diameter, or wall area cal-
culated from 2-dimensional ultrasound measures, pro-
vides information relevant to prevalent and incident
cardiac disease in addition to that provided by IMT.
Materials and methods
Atherosclerosis Risk in Communities Limited Access Data 
and Risk Factor Measurements
We examined the ARICLAD database, a subset of the
Atherosclerosis Risk in Communities (ARIC) Study data
consisting of participants who consented to data sharing
(99.6% of participants). Details regarding the purpose
and design of the ARIC Study have been published [33].
ARIC is a prospective study of 15,792 men and women,
ages 45–64 at baseline, who were randomly selected from
Forsyth County, North Carolina; Jackson, Mississippi;
suburbs of Minneapolis, Minnesota; and Washington
County, Maryland. Participants in Jackson were exclu-
sively black; participants in Minnesota and Washington
County were predominantly non-black (white); and
about 14% of Forsyth County participants were black. The
baseline clinic examination (exam 1) took place during
1987–1989 and three follow-up exams were conducted at
approximately 3-year intervals. Surveillance is ongoing in
the ARIC study [34]. For the current study we used the
Limited Access Data (LAD), for which follow-up for inci-
dent cardiac events is available through December 31,
1999.
The methods for the ARIC laboratory (white blood cell
count, glucose, LDL cholesterol, HDL cholesterol, and
fibrinogen) and other measurement procedures (blood
pressure, height and weight) have been summarized pre-
viously [35,36]. Prevalent diabetes mellitus was defined as
a fasting glucose level = 7.0 mmol/L (126 mg/dl), a non-
fasting level = 11.1 mmol/L (200 mg/dl), self-reported
physician diagnosis of diabetes, or use of medication for
diabetes within 2 weeks. The means of the second and
third values for sitting blood pressures (taken with a
standard clinical sphygmomanometer after a 5 minute
rest) were used. Hypertension was defined as blood pres-
sure ≥ 140/90 mm Hg or anti-hypertensive medication
use within 2 weeks. Current smoking and current alcohol
intake were based on self-report. For amount of alcohol
consumed, the usual number of drinks per week were con-
verted to grams/week [37]. Body mass index (BMI) was
calculated as weight in kilograms/height in meters2.
Prevalent and Incident Cardiac Events
Baseline prevalent myocardial infarction (MI) was based
on self-reported physician diagnosis of a heart attack or
changes on baseline study electrocardiogram (ECG). Inci-
dent cardiac events were ARIC adjudicated, definite or
probable MI from hospital surveillance, silent MI on a fol-
low-up study ECG, or definite fatal coronary heart disease
(CHD) from surveillance. Through annual telephone
interviews and surveillance of all area hospitals [34] pos-
sible cardiac events and deaths were identified for review
by trained abstractors. Chest pain, ECG, and cardiac
enzyme levels were used to categorize hospital events as
definite or probable MI. In-hospital deaths were catego-
rized as definite fatal CHD based on chest pain symp-
toms, underlying cause of death from the death certificate,
and relevant hospital and ARIC clinic information. Out of
hospital deaths were based on death certificates, and
information from the next of kin, the patient's physician,
the coroner, and autopsy or coroner reports, if available.
We use the term CHD to define a broader category of car-
diac events that also included cardiac procedures (coro-
nary bypass and angioplasty). The AUCs were determined
for incident events occurring within 10 years of follow-up.
B-mode Ultrasound Measurements
The ARIC ultrasound procedures were performed by
trained technicians using a Biosound 2000II Ultrasound
Imaging System[38]. As previously described [39,40], at
the baseline exam, each field center followed a standard
procedure where scans of three longitudinal views of the
carotids were recorded with the patient in a supine posi-
tion. Baseline scans were read later at a central reading
center [39]. The "optimal" view was the longitudinal viewCardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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with a visible flow divider and a visible carotid bulb origin
and was usually 10° to 20° above horizontal. Two addi-
tional views were taken at 55° above horizontal (anterior)
and 10° below horizontal (posterior). This study used
means of all available far wall IMT and external diameter
measurements from the distal 1 cm segment of the RCCA
where up to 11 measurements were possible. External
diameters did not include adventitia but were the dis-
tances between the near and far wall media-adventitial
interfaces. Plaques were not purposefully excluded from
CCA measurements [40]. In this study RCCA measure-
ments were used because of more complete information
[41] and because of similarity of risk factor associations
for right and left CCA diameters [9]. RCCA round and
elliptical wall areas calculations used in this study have
been previously described [42].
Study Population
From the 15,732 participants in the ARICLAD, 10000
were randomly selected as a developmental data set with
the remainder (5732) reserved as a test data set. Group
assignment was made prior to exclusions because the
samples were to be used in a series of studies requiring dif-
ferent exclusions. Participants were excluded if the follow-
ing information was missing: baseline prevalent MI or
CHD status (n = 347), ultrasound vascular measures
needed for wall area calculations (n = 3620), or data on
covariates (n = 540). The total effective baseline sample
was 11225 with a developmental data set of 7125 (3215
men and 3910 women) and a test data set of 4100 persons
(1846 men and 2254 women). Excluding 451 partici-
pants (347 men and 104 women) with a baseline MI, left
10774 (4714 men and 6060 women) for incident event
analyses.
Statistical Analysis
All statistical analyses were performed with SAS version
8.2 or 9.1. The cross-sectional and prospective associa-
tions for RCCA ultrasound measures with prevalent and
incident cardiac events were evaluated in the full sample
using logistic regression and Cox proportional hazards
models, respectively. One standard deviation (SD) of each
RCCA measure in the developmental data set served as the
unit of measure (IMT = 0.18 mm, diameter = 0.96 mm,
and wall area = 4.9 mm2). Because gender was an effect
modifier (interaction term p < 0.05) of the diameter-car-
diac event relationship, gender-specific models were
developed. Age was an effect modifier for vascular associ-
ations with incident cardiac events among men (interac-
tion term p < 0.05); thus, age-specific values were
determined for men.
Unadjusted models contained one of the following: IMT,
diameter, calculated wall area, or IMT + diameter. "Demo-
graphic" models added demographic variables of age and
ethnicity as well as height. Risk-adjusted models included
cardiovascular risk factors chosen from the developmen-
tal data set by stepwise logistic regression analyses after
forcing age and race into the gender-specific models.
Potential covariates included height (nearest cm), body
mass index (BMI) (weight in kg/height in m2), diabetes
mellitus, hypertension, LDL- and HDL-cholesterol
(mmol/L), systolic and diastolic blood pressures (mm
Hg), current smoking status, current drinking status and
ethanol consumption (grams/week), white blood cell
count (1000s / mm3), use of cholesterol lowering medica-
tion, glucose (mg/dl), and fibrinogen (mg/dl). Covariates
were identified separately for prevalent and incident car-
diac events. All covariates that were significant (p ≤ 0.05)
in any of the single vascular models (IMT, diameter, or
wall areas) were included so that models being compared
for specific outcomes differed only in the vascular meas-
ure(s) that were included. The AUC for both developmen-
tal and test data sets were based on the risks estimated for
each individual using coefficients identified from regres-
sion models for prevalent MI and incident cardiac events
[36]. The final model was stratified by baseline plaques/
shadowing status with CHD as the outcome.
Median values of IMT and diameter were used as the cut
points to categorize individuals as having large and not
large RCCA IMT and diameter (men: IMT 0.66 mm and
diameter 8.08 mm; women: IMT 0.62 mm and diameter
7.31 mm). Gender-specific event free survival functions
were plotted for the four IMT-diameter groups: large or
"normal" (not large) IMT and large or "normal" diameter
without further adjustment.
Results
The characteristics of the participants randomized to the
developmental and test data sets were similar. Only 1
characteristic (diabetes mellitus), out of 23 (data not
shown), differed significantly (p = 0.05) between the
developmental and test data sets (developmental data set
diabetes prevalence = 11.0%; test data set prevalence =
9.8%, p = 0.04). Thus, random assignment of participants
into developmental and test data sets appeared successful.
Baseline Characteristics
MI was identified at baseline in 289 (4.1%) of the 7125
persons in the developmental data set, and in 162 (4.0%)
of the 4100 individuals in the test data set. Incident car-
diac events occurred in 3.8% of women and 8.8% of men
through 1999. Characteristics of the study population at
baseline, overall and by baseline MI status, are provided
in Table 1. Participants with MI at baseline were older and
had a significantly higher prevalence of several cardiovas-
cular risk factors (male gender, diabetes, hypertension,
current smoking and non-drinking) than those without
an MI. Detrimental cross-sectional associations were alsoCardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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found for several continuous risk factors with BMI, LDL,
fasting glucose, white blood count, and fibrinogen being
higher, and HDL being lower in persons with, compared
to those without MI. Persons with prevalent MI had signif-
icantly thicker RCCA IMT and larger RCCA diameter and
RCCA wall areas than persons without MI.
Association of Vascular Measures with Prevalent and 
Incident Cardiac Events
For both men and women, when evaluated in separate
models, RCCA IMT, diameter, and wall area were posi-
tively associated with baseline prevalent MI (Table 2) and
with incident cardiac events (Tables 3, and 4) and gener-
ally remained statistically significant after risk factor
adjustment. Among women, for both prevalent MI (Table
2) and incident cardiac events (Table 3), associations were
stronger for diameter than IMT, and wall area associations
were of intermediate strength. Risk factor adjustment
attenuated diameter's effect to a greater degree for incident
than prevalent events (74.3% vs. 33.6% risk reduction
respectively) among women. Among men, there was little
disparity in the overall strengths of the vascular measure
associations for either prevalent (Table 2) or incident
events (Table 4). IMT, diameter, and wall area associa-
tions with incident cardiac events were stronger among
men who were 54 years of age or younger compared to
older men (Table 4).
Cardiac Events Including Procedures
The association with prevalent and incident CHD (includ-
ing coronary procedures) among women was stronger for
RCCA diameter than IMT, regardless of plaque/shadow-
ing status (Table 5). RCCA wall area produced an effect
intermediate between IMT and diameter among women.
Among men, the IMT associations were similar to the IMT
associations found among women. However, the diame-
ter and wall area associations for men were much weaker
for both prevalent and incident CHD than the associa-
Table 1: Baseline characteristics for the developmental data set and for subsets with and without prevalent myocardial infarction at 
baseline, ARICLAD, 1987–89
Baseline Myocardial Infarction
Developmental Sample Absent Present
N = 7125 N = 6836 N = 289
Age in years 54.2 ± 5.7 54.1 ± 5.7 56.9 ± 5.1***
Gender (% male) 45.1 43.8 76.1***
Race (% nonwhite) 25.9 25.9 23.9
Diabetes (%) 9.8 9.2 23.2***
Hypertension (%) 33.0 32.2 52.6***
Height in cm 168.5 ±9.3 168.4 ± 9.3 172.1 ± 8.0***
BMI (kg/m2) 27.2 ± 5.0 27.1 ± 5.0 27.9 ± 5.2**
LDL-C (mmol/L) 3.55 ±1.02 3.54 ± 1.02 3.78 ± 1.03***
HDL-C (mmol/L) 1.36 ± 0.45 1.37 ± 0.45 1.11 ± 0.38***
Cholesterol Med. (% use) 2.6 2.5 5.2**
Fasting glucose (mg%)† 106.7 ± 36.2 106.2 ± 35.6 117.3 ± 46.5***
White blood count (1000s/ml) 6.10 ± 1.94 6.08 ± 1.93 6.74 ± 1.99***
Fibrinogen (mg/dl)‡ 302.4 ± 65.2 301.4 ± 64.8 327.2 ± 70.8***
Current drinker (%) 57.2 57.5 49.1**
Current smoker (%) 27.2 27.0 32.5*
Systolic BP (mm Hg) 121.0 ± 18.7 120.9 ± 18.6 121.7 ± 21.1
Diastolic BP (mm Hg) 73.4 ± 11.3 73.5 ± 11.2 72.1 ± 12.2
RCCA IMT in mm 0.66 ± 0.18 0.66 ± 0.17 0.74 ± 0.25***
RCCA diameter in mm 7.78 ± 0.95 7.76 ± 0.94 8.32 ± 1.08***
RCCA wall area in mm2 14.97 ± 4.94 14.85 ± 4.81 17.83 ± 6.73***
Values are expressed as percent or as means ± standard deviation
ARICLAD: Atherosclerosis Risk in Communities Limited Access Data
BMI: body mass index= weight in kg/height in meters2
BP: blood pressure
HDL- and LDL-cholesterol: high and low density lipoprotein cholesterol
IMT: intima medial thickness
RCCA: right common carotid artery
† Conversion factor = 0.0555 to convert to mmol/L
‡Conversion factor = 0.0294 to convert to µmol/L
*p-values = 0.05 **p-value = 0.005 ***p-value = 0.0005 for chi-square and Wilcoxon two-sample test for difference in the characteristic by baseline 
myocardial infarction statusCardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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tions found for women. For women the diameter associa-
tions were generally stronger in the absence of plaques/
shadowing. Risk factor adjustment consistently reduced
diameter associations for incident CHD in both genders
regardless of baseline plaques/shadowing status, but
adjustment produced less consistent attenuation for prev-
alent CHD.
Model Discrimination for Prevalent and Incident Cardiac 
Events
The receiver operator characteristic curve plots the sensi-
tivity vs. 1 – specificity and the AUC is the associated
measure of the model's discrimination of the outcome for
individuals [36]. For men, unadjusted model discrimina-
tion varied between the developmental and test data sets
(Tables 2 and 4). Neither IMT nor diameter provided con-
sistently better discrimination. Wall area or IMT+diameter
provided more consistent discrimination for incident and
prevalent events across subsets of men than either IMT or
diameter alone.
The AUCs were consistently larger for women than men in
both prevalent and incident analyses (Tables 2 and 3).
Among women when adjustment was limited, models
with diameter had consistently larger AUC than models
with IMT in both developmental and test data sets for
prevalent (Table 2 right: AUC differences ≈ 0.06 for unad-
justed models, ≈ 0.04 for demographic models) and inci-
dent models (Table 3 right: AUC differences ≈ 0.07 for
unadjusted and ≈ 0.04 for demographic models). After
risk factor adjustment, little difference remained for prev-
alent MI (Table 2: AUC differences ≈ 0.03) and incident
cardiac events (Table 3: AUC differences ≈ 0.001 and
0.007 in developmental and test data sets respectively).
Wall area models were generally intermediate in discrim-
ination between IMT and diameter models.
For both men and women (Figures 1a and 1b), those who
had both large diameter and large IMT had the poorest
event-free survival of all four IMT-diameter groups. For
men, the remaining three categories diverged only mod-
Table 2: Baseline cross-sectional associations between B-mode ultrasound RCCA measures and prevalent MI and the discrimination of 
the respective models in the developmental and test data sets of the ARICLAD, 1987–89
Vascular Measures' Association with Prevalent MI Discrimination of Prevalent MI
Men, Data Sets Women, Data Sets
Model RCCA
Measure
Men
N = 5061
OR (95% CI)*
Women
N = 6164
OR (95% CI)*
Development
N = 3215
AUC
Test
N = 1846
AUC
Development
N = 3910
AUC
Test
N = 2254
AUC
1 IMT 1.32 (1.22–1.43) 1.36 (1.18–1.55) 0.586 0.616 0.631 0.632
2 IMT 1.23 (1.13–1.34) 1.21 (1.02–1.42) 0.640 0.676 0.681 0.682
3 IMT 1.17 (1.07–1.28) 1.17 (0.99–1.38) 0.753 0.749 0.741 0.690
1 Diameter 1.29 (1.16–1.43) 2.10 (1.73–2.55) 0.551 0.614 0.689 0.687
2 Diameter 1.21 (1.08–1.35) 1.81 (1.47–2.24) 0634 0.680 0.717 0.719
3 Diameter 1.14 (1.02–1.28) 1.73 (1.40–2.14) 0.750 0.747 0.766 0.718
1 Wall area 1.36 (1.25–1.48) 1.60 (1.38–1.86) 0.585 0.638 0.678 0.675
2 Wall area 1.27 (1.16–1.39) 1.40 (1.19–1.66) 0.639 0.684 0.700 0.697
3 Wall area 1.20 (1.09–1.32) 1.35 (1.14–1.60) 0.753 0.751 0.753 0.700
Model Two Measures Men
OR (95% CI)
Women
OR (95% CI)
Men Women
Developmental Test Developmental Test
1 IMT + Diameter 1.27 (1.16–1.38)
1.16 (1.04–1.30)
1.09 (0.91–1.3)
2.00 (1.61–2.49)
0.586 0.644 0.696 0.687
2 IMT + Diameter 1.19 (1.09–1.31)
1.13(1.01–1.27)
1.02 (0.84–1.24)
1.80 (1.43–2.25)
0.640 0.689 0.719 0.717
3 IMT + Diameter 1.15 (1.05–1.26)
1.09 (0.97–1.23)
1.01 (0.83–1.22)
1.73 (1.37–2.17)
0.753 0.750 0.767 0.716
OR: odds ratio for 1 standard deviation increment of the vascular measure
CI: confidence interval
Model 1: vascular measure(s) only; Model 2: add age, race, and height; Model 3 for men: age, race, diabetes mellitus, systolic blood pressure, 
fibrinogen, HDL and LDL cholesterol, and hypertension; Model 3 for women: age, race, current drinking status, HDL cholesterol, diastolic blood 
pressure and white blood count.Cardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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estly and only late in follow up. Women with large diam-
eters but normal IMT had the second poorest survival of
the four groups.
Discussion
The current study provides evidence suggesting the impor-
tance of measuring arterial diameter, as well as IMT, in
studies of atherosclerosis. The largest reduction in event
free survival among both men and women occurred
among persons having diameter enlargement as well as
thickened IMT. Changes in diameter effect size after
adjustment for IMT and risk factors suggest that risk fac-
tors contribute to cardiac events through diameter and
IMT changes.
The present study confirmed an association between
RCCA diameter and prevalent and incident cardiac events
for both men and women with evidence of independence
from many traditional risk factors when IMT and diameter
were evaluated separately. Among women, even with
RCCA IMT included as a risk factor, diameter was inde-
pendently associated with incident cardiac events; and
models for women with diameter alone or diameter + IMT
provided generally better discrimination than models
with IMT alone. In evaluations of prevalent and incident
cardiac events for men, model discrimination was gener-
ally more consistent across test and developmental sub-
sets when RCCA wall area or both IMT and diameter were
included in the models. Both men and women with
enlarged diameter and IMT had the poorest event-free sur-
vival. Since plaque prevalence has been associated with
cardiovascular events even after control for IMT [14], our
hypothesis was that diameter would improve prediction
of cardiac events by providing an indication of the pres-
ence and severity of plaques. However, diameter may
indicate not only plaque presence [43] or vulnerability
[26,27], but also responses to hemodynamic factors
[44,45], to aging [41,46], to the metabolic syndrome [20],
or to other factors. The stronger association with cardiac
events in the absence of plaques in our study supports the
view that diameter indicates more than just plaque pres-
ence/severity.
It should not be surprising that IMT and diameter may
have independent effects on both prevalent and incident
cardiac events given that IMT and diameter have some-
what different risk factor relationships [9,13,17,28,47].
Thus, conditions related to diameter such as the metabolic
syndrome [20] or novel risk factors [48,49] may lead to
diameter enlargement early in the atherosclerotic process.
Table 3: Among women, the risk associated with RCCA B-mode ultrasound vascular measures and the model discrimination in the 
developmental and test data sets of the ARICLAD, 1987–99
Incident Cardiac Events
Vascular Measure Risk Model Discrimination
Overall Developmental Test
Model RCCA Measure N = 6060 N = 3841 N = 2219
HR (95% CI) AUC AUC
1 IMT 1.49 (1.38–1.61) 0.621 0.608
2 IMT 1.40 (1.28–1.53) 0.682 0.675
3 IMT 1.19 (1.08–1.31) 0.830 0.805
1 diameter 2.01 (1.76–2.29) 0.696 0.679
2 diameter 1.83 (1.59–2.11) 0.724 0.712
3 diameter 1.26 (1.08–1.48) 0.831 0.812
1 Wall area 1.65 (1.52–1.78) 0.680 0.661
2 Wall area 1.56 (1.42–1.71) 0.702 0.699
3 Wall area 1.23 (1.10–1.38) 0.831 0.808
Model Two Measures HR (95% CI) Developmental Test
AUC AUC
1 IMT +
diameter
1.26 (1.15–1.39)
1.75 (1.51–2.02)
0.705 0.674
2 IMT +
diameter
1.23 (1.10–1.37)
1.65 (1.42–1.93)
0.724 0.705
3 IMT +
diameter
1.14 (1.03–1.27)
1.18 (1.00–1.40)
0.831 0.805
HR = hazards ratio for 1 standard deviation increment of the vascular measure in Cox proportional hazards models. CI: confidence interval
Model 1: vascular measure(s) only; Model 2 covariates: age, race, and height;
Model 3 covariates: age, race, systolic blood pressure, diabetes mellitus, HDL and LDL cholesterol, blood glucose, fibrinogen, current drinking, and 
current smoking.Cardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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Later, outward vascular remodeling in response to athero-
sclerotic plaques may result in diameter enlargement.
Also, arterial diameters enlarge with age [18,41]. Thus,
diameter may reflect the impact of different factors
depending upon the person's age and stage of atheroscle-
rosis. Gender differences may reflect the different stage of
atherosclerosis found among men and women of similar
ages. The lower overall incidence of events among women
contributed to the higher relative risk associated with
diameter compared to men whose absolute risk was
higher. It is possible that diameter changes contribute to
the heterogeneity of IMT effect with age that was reported
in a recent meta-analysis [50].
Artery and plaque dimensions have been previously
related to cardiovascular events [19,21,28,31]. In a study
of symptomatic patients, Nowak et. al. found that that left
CCA intima-medial wall area was a better indicator of the
extent of angiographically determined coronary artery dis-
ease than IMT [31]. In a small clinical study, patients with
acute coronary syndrome had larger right and left carotid
lumen diameters than persons with stable angina [22]. In
our study, diameter complemented IMT for risk discrimi-
nation of cardiac events, especially with limited risk factor
information. Among men, inclusion of both IMT and
diameter produced discrimination of events that was
more consistent across subsets than either IMT or diame-
ter alone. Among women, diameter was a stronger risk
discriminator than IMT, especially at basic levels of adjust-
ment. While sophisticated techniques for evaluating 3-
dimensional artery and plaques may provide more precise
measurements [5-7,29], B-mode ultrasound is more
widely available and less expensive, and its usefulness
may be improved by evaluating both RCCA IMT and
diameter.
Results from our study raise the question of whether dif-
ferences in initial vascular size may influence arterial
response to shear stress. As plaques develop and encroach
on the artery lumen, arteries enlarge to maintain blood
flow and levels of shear stress [51]. Larger arteries would
need to enlarge less to preserve lumen area than smaller
arteries [42]. Thus, the larger CCAs in healthy men than in
women [41], and the larger diameters at older ages even
in healthy populations, might explain the stronger diam-
eter associations found for women compared to men and
for younger versus older men. Age might also explain the
minimal effect reported in the Rotterdam Study, a study of
a higher risk, older population (age ≥ 55 years), where 1
SD of arterial mass (wall area) had a minimally higher HR
compared to 1 SD of IMT [30], but no improvement in the
AUC was seen. Thus, the effects of ectasia associated with
normal aging may dilute any attempt to identify detri-
mental effects associated with diameter among the eld-
Table 4: Among men, the overall and age-specific risks associated with RCCA B-mode ultrasound vascular measures and the 
discrimination for the overall models in the developmental and test data sets of the ARICLAD, 1987–99
Risk for Incident Cardiac Events Model Discrimination for All Ages
Model RCCA Measure All
N = 4714
Age ≤ 54
N = 2415
Age > 54
N = 2299
Development
N = 2995
Test
N = 1719
HR (95% CI) HR (95% CI) HR (95% CI) AUC AUC
1 IMT 1.26 (1.17–1.34) 1.36 (1.23–1.50) 1.14 (1.04–1.25) 0.597 0.606
2 IMT 1.20 (1.11–1.29) 1.35 (1.22–1.50) 1.11 (1.01–1.23) 0.626 0.633
3 IMT 1.10 (1.02–1.18) 1.22 (1.10–1.36) 1.04 (0.94–1.14) 0.718 0.710
1 diameter 1.36 (1.24–1.49) 1.40 (1.21–1.62) 1.26 (1.13–1.42) 0.599 0.608
2 diameter 1.30 (1.18–1.42) 1.40 (1.20–1.62) 1.24 (1.10–1.40) 0.629 0.633
3 diameter 1.19 (1.08–1.32) 1.28 (1.09–1.49) 1.16 (1.02–1.31) 0.719 0.713
1 Wall area 1.33 (1.24–1.42) 1.45 (1.30–1.61) 1.20 (1.09–1.29) 0.614 0.636
2 Wall area 1.26 (1.17–1.37) 1.41 (1.29–1.61) 1.17 (1.06–1.29) 0.636 0.653
3 Wall area 1.15 (1.06–1.24) 1.29 (1.15–1.45) 1.08 (0.98–1.20) 0.721 0.711
Model Double vascular All Age ≤ 54 Age >54
1 IMT +
diameter
1.18 (1.09–1.27)
1.27 (1.15–1.40)
1.28 (1.14–1.44)
1.26 (1.07–1.48)
1.08 (0.97–1.20)
1.23 (1.09–1.39)
0.616 0.636
2 IMT +
diameter
1.13 (1.05–1.23)
1.24 (1.12–1.37)
1.27 (1.14–1.43)
1.26 (1.07–1.49)
1.05 (0.95–1.18)
1.22 (1.08–1.38)
0.637 0.652
3 IMT +
diameter
1.06 (0.98–1.15)
1.17 (1.06–1.29)
1.17 (1.04–1.32)
1.20 (1.02–1.42)
1.01 (0.91–1.12)
1.16 (1.02–1.31)
0.721 0.713
HR = hazards ratio for 1 standard deviation increment of the vascular measure
Model 1: vascular measure(s) only; Model 2 covariates: age, race, and height; Model 3 covariates: age, race, BMI, HDL and LDL cholesterol, diabetes 
mellitus, fibrinogen, hypertension, and current smoking.C
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Table 5: Relationships between RCCA ultrasound measures and prevalent and incident CHD among men and women with and without carotid plaques/shadowing†at baseline, 
ARICLAD
Prevalent Coronary Heart Disease, 1987–1989 Incident Coronary Heart Disease to 12/1999
Men
OR, 95% CI§ 
Plaques/Shadowing:
Women
OR, 95% CI§ 
Plaques/Shadowing:
Men
HR, 95% CI§ 
Plaques/Shadowing:
Women
HR, 95% CI§ 
Plaques/Shadowing:
Model RCCA
Measure
No (n = 2277) Yes (n = 1867) No (n = 3550) Yes (n = 1657) No (n = 2150) Yes (n = 1677) No (n = 3503) Yes(n = 1603)
2‡ IMT 1.16 1.23 1.27 1.21 1.21 1.15 1.18 1.27
0.94–1.44 1.10–1.37 0.88–1.84 1.01–1.45 1.02–1.42 1.06–1.25 0.92–1.52 1.13–1.42
3‡ IMT 1.13 1.19 1.29 1.17 1.10 1.07 1.00 1.09
0.90–1.42 1.07–1.33 0.90–1.86 0.97–1.41 0.93–1.30 0.99–1.16 0.78–1.28 0.96–1.23
2‡ Diameter 1.27 1.10 1.91 1.50 1.17 1.22 1.83 1.60
1.05–1.54 0.95–1.27 1.35–2.71 1.13–1.98 1.00–1.36 1.10–1.36 1.45–2.30 1.35–1.91
3‡ Diameter 1.30 1.01 1.89 1.44 1.10 1.14 1.25 1.22
1.06–1.59 0.87–1.19 1.34–2.68 1.08–1.93 0.93–1.29 1.02–1.28 0.97–1.60 1.00–1.49
2‡ Wall Area 1.23 1.24 1.59 1.31 1.24 1.20 1.62 1.37
1.00–1.52 1.11–1.39 1.11–2.29 1.07–1.61 1.05–1.45 1.10–1.32 1.29–2.03 1.22–1.54
3‡ Wall Area 1.23 1.18 1.63 1.26 1.13 1.11 0.88 1.12
0.99–1.54 1.05–1.34 1.13–2.35 1.02–1.56 0.96–1.34 1.02–1.22 0.61–1.26 0.97–1.28
Model Two Measures
2‡ IMT 1.08 1.23 1.01 1.12 1.16 1.11 0.94 1.14
0.86–1.36 1.10–1.37 0.67–1.50 0.91–1.37 0.98–1.38 1.01–1.22 0.72–1.24 1.00–1.30
+ Diameter 1.24 1.01 1.97 1.44 1.11 1.18 1.87 1.50
1.01–1.52 0.86–1.18 1.33–2.92 1.05–1.97 0.95–1.31 1.05–1.32 1.45–2.40 1.24–1.81
3‡ IMT 1.05 1.20 1.06 1.09 1.08 1.05 0.92 1.04
0.82–1.33 1.07–1.34 0.71–1.57 0.89–1.34 0.91–1.28 0.96–1.15 0.70–1.20 0.91–1.20
+ Diameter 1.29 0.96 1.86 1.38 1.08 1.13 1.29 1.19
1.04–1.59 0.81–1.12 1.28–2.70 1.02–1.88 0.91–1.28 1.00–1.27 0.99–1.68 0.96–1.48
§Odds ratios (OR) or hazards ratio (HR) associated with an increment of 1 standard deviation of the vascular measure in the logistic and Cox proportional hazards models respectively
†Plaques or shadowing at any right or left carotid site (internal, CCA, or bifurcation)
‡Models 2 and 3 are demographic and risk factor adjusted models respectively. The covariates for prevalent disease are found in Table 2 and those for incident events are listed in Table 3 for women 
and Table 4 for men.
CHD, coronary heart disease that includes coronary artery procedures.Cardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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a and b: Gender-specific survival functions for four IMT-diameter groups, unadjusted for risk factors Figure 1
a and b: Gender-specific survival functions for four IMT-diameter groups, unadjusted for risk factors. Black solid line (ll) indi-
cates large IMT and large diameter group; blue dashed line (ln) indicates large IMT and normal diameter group; red dotted line 
(nl) indicates normal IMT and large diameter group; green dot-dash line (nn) indicates normal IMT and normal diameter group.Cardiovascular Ultrasound 2007, 5:11 http://www.cardiovascularultrasound.com/content/5/1/11
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erly. Thus, diameter may be a surrogate for different
factors at various ages or stages of disease.
In our study, inclusion of covariates that optimized all
vascular measure models, allowed an unbiased compari-
son of vascular models' discrimination, but prevents com-
parison of the AUCs with other reported predictive
models that included different covariates [2,36]. A poten-
tial for misclassification by plaque status exists in the
ARIC study [52], potentially impacting our analyses that
were stratified by plaques/shadowing status. Finally, cor-
relation of vascular measures and risk factors [2], and mis-
classification of the outcome [53] may prevent further
improvement in model discrimination. While many man-
uscripts based on the full ARIC data use IMT measures
that have been reader trend adjusted, those values are not
available in the limited access data used in this study.
In conclusion, B-mode ultrasound of the carotid artery
can be used to assess the presence and extent of vascular
disease, even at an early stage. Our study suggests that
diameter complements IMT as an indicator of atheroscle-
rosis. Consideration of arterial diameter along with arte-
rial wall thickness may provide insights into progression
to cardiovascular disease events.
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